## Abstract The underlying genetic events associated with follicular thyroid tumorigenesis are still ill defined. In this study, we performed a screening for chromosome imbalances by comparative genomic hybridization (CGH) in a group of 12 follicular adenomas (FAs) and 20 follicular carcinomas (FTC
Differentiated thyroid carcinoma: Comparison between papillary and follicular carcinoma in a single institute
β Scribed by Sin-Ming Chow; Stephen C. K. Law; Siu-Kie Au; To-Wai Leung; Paddy T. M. Chan; William M. Mendenhall; Wai-Hon Lau
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 106 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Purpose:
To compare and contrast the clinical presentation and treatment outcome of patients with papillary and follicular thyroid carcinoma and to study the pattern of practice of treatment of differentiated thyroid carcinoma in hong kong.
Method:
The clinical presentation and treatment outcomes were reviewed for 1057 patients with differentiated thyroid cancers who were treated at the queen elizabeth hospital, hong kong, from 1960 to 1997. eight hundred forty-two patients had papillary thyroid carcinomas (ptc), and 215 had follicular thyroid carcinomas (ftc). the mean follow-up was 9.2 years.
Results:
The differences in the clinical factors of ptc to ftc were as follows: ptc had a higher incidence (3.9:1); these patients were younger at presentation (median age, 44 vs 49), showed a higher female-male ratio (4.5 vs 2.9) and smaller primary tumor size (median 2 cm vs 3.5 cm), and a higher incidence of multifocal disease (28.3% vs 18.1%), extrathyroidal extension (39.4% vs 14%), and more lymph node metastases (33.3% vs 12.1%). the incidence of distant metastases was higher for patients with ftc (28.8% vs 8.9%), and cause-specific survival rates were lower (p =.001). the locoregional control rates were not significantly different (p =.2). the 10-year cause-specific survival, freedom from distant metastasis, and locoregional failure figures for ptc compared with ftc were 92.1% vs 81%, 90.8% vs 72.3%, and 78.5% vs 83%.
Conclusions:
Although patients with ptc tend to have more advanced locoregional disease compared with those with ftc, the likelihood of locoregional control is similar, and the probability of cure is better.
π SIMILAR VOLUMES
We describe 11 cases (8 females, 3 males) of papillary thyroid carcinoma in children treated at St. Jude Children's Research Hospital over a 33-year period, and review the literature. Ages ranged from 7-25 years (median, 16 years). Six patients had primary papillary thyroid carcinoma. Five patients
## Abstract ## BACKGROUND There is continuous debate regarding the optimal classification, prognosis, and treatment of the follicular variant of papillary thyroid carcinoma (FVPTC). The objective of this study was to assess the behavior of FVPTC, especially its encapsulated form, and shed more lig
## Abstract The majority of thyroid tumors are classified as papillary (papillary thyroid carcinomas; PTCs) or follicular neoplasms (follicular thyroid adenomas and carcinomas; FTA/FTC) based on nuclear features and the cellular growth pattern. However, classification of the follicular variant of p